S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Your Money is Not Safe (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Your Money is Not Safe (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Your Money is Not Safe (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Your Money is Not Safe (Ad)
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
Free Trial
OTCMKTS:ONPH

Oncology Pharma (ONPH) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)
Free ONPH Stock Alerts
$0.0005
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.0005
▼
$0.0005
50-Day Range
N/A
52-Week Range
$0.00
▼
$1.05
Volume
540 shs
Average Volume
3,907 shs
Market Capitalization
$19,330.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesShort Interest
ONPH stock logo

About Oncology Pharma Stock (OTCMKTS:ONPH)

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

ONPH Stock Price History

ONPH Stock News Headlines

April 17, 2024 | markets.businessinsider.com
Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement
April 12, 2024 | bloomberg.com
Nuclear Medicine Is Big Pharma’s New Target in Cancer Race
April 19, 2024 | Darwin (Ad)
Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report
Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)
April 10, 2024 | businesswire.com
Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment
April 9, 2024 | msn.com
Boehringer Ingelheim Upbeat On China, Forms Cancer Drug Partnership
April 4, 2024 | msn.com
Kintara and TuHURA enter merger deal to advance oncology pipeline
April 4, 2024 | msn.com
Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round
April 4, 2024 | msn.com
A new hope in immunotherapy against cancer
April 19, 2024 | Darwin (Ad)
Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report
Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)
March 26, 2024 | msn.com
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
March 25, 2024 | msn.com
US FDA declines to approve Regeneron's blood cancer therapy
March 21, 2024 | bizjournals.com
Clinical trial results show new Penn technology could be the key to fighting brain cancer
March 12, 2024 | msn.com
AbilityPharma receives funds to advance pancreatic cancer trial
March 4, 2024 | msn.com
Iovance stock rises after FDA lifts clinical hold on lung cancer trial
February 27, 2024 | benzinga.com
Oncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and Dates
February 27, 2024 | benzinga.com
Oncology Pharma Stock (OTC:ONPH), Analyst Ratings, Price Targets, Predictions
February 20, 2024 | msn.com
The doctor behind the next big thing in cancer treatment
February 20, 2024 | msn.com
The woman behind the next big thing in cancer treatment
February 19, 2024 | msn.com
Positive signs for new cancer treatment after trial on Oxford patients
February 17, 2024 | msn.com
UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy
February 16, 2024 | reuters.com
US FDA grants accelerated approval for Iovance's skin cancer cell therapy
February 15, 2024 | msn.com
Cancer breakthrough as doctors celebrate new ‘wonder drug’
February 15, 2024 | msn.com
Ono and Numab to develop antibody for cancer treatment
February 9, 2024 | msn.com
Boehringer and CBmed partner to develop cancer therapies
February 4, 2024 | tmcnet.com
Accord Healthcare partners with ITN Business for World Cancer Day to explore how innovative approaches are helping shape the future of cancer care
February 2, 2024 | msn.com
NeoPhore adds $12.2m in Series B extension for immuno-oncology pipeline
January 30, 2024 | msn.com
Kiromic BioPharma reports data from lung cancer therapy trial
See More Headlines
Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
3/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
OTCMKTS:ONPH
CUSIP
N/A
CIK
N/A
Web
www.oncology-pharma.com
Phone
(415) 869-1038
Fax
858-385-8997
Employees
1
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
38,660,000
Free Float
31,704,000
Market Cap
$19,330.00
Optionable
Not Optionable
Beta
-0.91
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Chuck Wagner
    President, Treasurer & Chairman
  • Mr. George Malesek
    Interim Chief Executive Officer
  • Mr. Dimitri Theofilopolous Esq.
    Legal Counsel

Key Competitors

View All Competitors

ONPH Stock Analysis - Frequently Asked Questions

How have ONPH shares performed in 2024?

Oncology Pharma's stock was trading at $0.0002 at the start of the year. Since then, ONPH stock has increased by 150.0% and is now trading at $0.0005.
View the best growth stocks for 2024 here.

How do I buy shares of Oncology Pharma?

Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ONPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes